Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling - Wikidata - wikimedia - TriplyDB

Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling

Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling

http://www.wikidata.org/entity/Q57312498

about

Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction Circulating plasma serine208-phosphorylated troponin T levels are indicator of cardiac dysfunction.Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.Heart rate: a forgotten link in coronary artery disease?Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.Heart rate reduction in heart failure: ivabradine or beta blockers?Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.HCN channels--modulators of cardiac and neuronal excitability.Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.HCN Channels Modulators: The Need for Selectivity.Heart rate reduction in coronary artery disease and heart failure.Hyperpolarization-activated cyclic nucleotide-gated channels and ventricular arrhythmias in heart failure: a novel target for therapy?Influence of ivabradine on reverse remodelling during mechanical unloading.Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina

P2860

Q30276924-1CBC682B-38E0-499A-825B-A1F2C98D9C73 Q34154800-E7B96707-09D8-4D5E-9AAD-B274E3F34AED Q34326097-FF511ECA-D092-4C12-889A-96356BA84499 Q34631911-A083A439-5042-47A1-9CE6-17896A00287C Q36024921-843413C2-296F-4EB9-8081-22B60A5C0E74 Q36159185-7BB9A7DD-1E42-427C-92E1-EB5E2A97EB7D Q37857335-515D0499-BCCE-428B-8A14-025C1C17D379 Q37868929-8A5E2DFE-9556-4020-99D1-7408D5BA1FC6 Q37923966-D058C53C-C96A-4C0B-8970-961C99B6ECA2 Q38042855-27AD2792-273D-472B-9BB7-E082F890A31A Q38142792-2D3C1978-BC6A-4F51-A3E2-24451D70EABA Q38314976-E7EF4FB8-3428-4FD2-A8BF-28F62E6362DF Q38547852-7F7F6AF8-A11F-4535-A298-946ABBD1AA2C Q38621386-B2E3FCB9-35E4-4E5F-8432-49422DFB5AA1 Q38774251-EE84B030-0186-48EB-8039-85E8542C52AE Q38844531-6D6E3B0C-1D54-4BBC-A5FB-B7CD491F854E Q43109027-481BBDD4-75A0-4472-925D-E0BBD2163088 Q44117604-7B5C5474-C144-45FF-B476-70A0F548CA2C Q46031161-57E0E9F5-3585-4DA2-9A2C-FDFCB52EDCE4 Q46222726-E121E852-0A13-458F-8257-DCCC2D4E71AF Q51738137-6B83B586-85FA-4E35-A74D-935137C39B27 Q57312494-EA51BCD7-6DB3-495E-945C-272D41617C8E

P2860

Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling

http://www.wikidata.org/entity/Q57312498

description

article

@en

im Januar 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2011

@uk

name

Heart rate reduction with ivab ...... of left ventricular remodeling

@en

Heart rate reduction with ivab ...... of left ventricular remodeling

@nl

type

label

Heart rate reduction with ivab ...... of left ventricular remodeling

@en

Heart rate reduction with ivab ...... of left ventricular remodeling

@nl

prefLabel

Heart rate reduction with ivab ...... of left ventricular remodeling

@en

Heart rate reduction with ivab ...... of left ventricular remodeling

@nl

P1433

Q57312498-8980E812-B91E-485E-883A-9924170F8B26

P1476

Q57312498-D9FB4DC3-E984-422F-9C6B-D08D011C55D9

P2093

Q57312498-0CC1DE4F-20CE-46CB-A9B8-0E4733B9DB69

Q57312498-4D6B7866-D386-4340-8CBE-92C2B0362BDE

Q57312498-9EA1EE4B-2C96-40E1-8BE5-A4EF97878ED0

Q57312498-EAF8F92D-F882-44CA-8883-817442E3BC05

Q57312498-FC2A36C1-ADB1-4565-B6D7-28EDE7A49CB7

P2860

Q57312498-0804E4E4-5206-412A-A188-0B1155FEFD42

Q57312498-08312141-56D2-4548-8900-6B520E71A1AB

Q57312498-09654DE6-09CF-4B0F-B681-FD688B35413E

Q57312498-0CC97222-E779-4215-9F3D-1172BCE0B2C1

Q57312498-13B36E91-DA93-462B-903F-B4A43BF895E1

Q57312498-14D24115-BA91-4500-B0AB-5175CBEF7CCB

Q57312498-19008340-763A-4640-A1FF-64231393A25F

Q57312498-1B930929-F432-4787-A68E-5B6955904EDF

Q57312498-2424B4FB-DE7E-41D0-8A45-8ADFF59BC21A

Q57312498-26F7F6E4-126D-4075-9F12-3452996EC532

P304

Q57312498-4D931A5A-84AF-4DDE-8B2D-F541D7181552

P31

Q57312498-DF325E62-C4A9-4413-8485-6F0184CAA24E

P356

Q57312498-01BE6990-169D-4896-8EB3-630F7147C958

P433

Q57312498-70E662D9-37FD-4603-826F-DF55AF7A497B

P478

Q57312498-67AF5F01-F8A6-4EE0-9873-4F45B0216E5B

P50

Q57312498-0F17357F-FB77-4AE1-A10A-0035FCCE7EC4

Q57312498-77BA6E83-5B35-4C85-B943-5BD4A4FAAEAF

Q57312498-B83D1754-8956-4456-B28F-EAD6B121BF4C

P577

Q57312498-BB5F64B2-1A3B-435E-88B6-4BC337C00F54

P698

Q57312498-0BD0E6AD-31EB-4C4B-B1F1-9287415A38CA

P356

AJPHEART.01117.2009

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Heart rate reduction with ivab ...... of left ventricular remodeling

@en

P2093

Alessandro Mugelli

http://www.w3.org/2001/XMLSchema#string

Laura Comini

http://www.w3.org/2001/XMLSchema#string

Muriel Bouly

http://www.w3.org/2001/XMLSchema#string

Roberto Ferrari

http://www.w3.org/2001/XMLSchema#string

Silvia Suffredini

http://www.w3.org/2001/XMLSchema#string

P2860

Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

The failing heart--an engine out of fuel

Electrophysiological remodeling in hypertrophy and heart failure.

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

P304

H366-H373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.01117.2009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P50

Elisabetta Cerbai

Francesca Stillitano

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20952661

http://www.w3.org/2001/XMLSchema#string